Mark Shearman

Chief Executive Officer at

Aprinoia Therapeutics, Inc. /US/

64 year

Health Technology

Consumer Services

Profile

Mark S.
Shearman is currently the Chief Executive Officer & Director at Aprinoia Therapeutics, Inc. He previously held positions as the Executive Director-Neuroscience at Merck & Co., Inc., the Executive Director at Merck Research Laboratories Massachusetts LLC, and the Senior Director-Cellular & Molecular Neuroscience at Merck Sharp & Dohme Research Laboratories Neuroscience Research.
He also served as the Senior VP-Research & Early Development at Merck KGaA and the Chief Scientific Officer & Vice President at Beacon Therapeutics (USA), Inc. Dr. Shearman's most recent former position was as the Chief Scientific Officer & Executive VP at Editas Medicine, Inc. He received his undergraduate degree from the University of Bristol and his doctorate from The University of Nottingham.

Mark Shearman active positions

Companies	Position	Start
Aprinoia Therapeutics, Inc. /US/ Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on neurodegenerative diseases	Chief Executive Officer	14/07/2023

All active positions of Mark Shearman

Former positions of Mark Shearman

Companies	Position	End
APPLIED GENETIC TECHNOLOGIES CORPORATION	Chief Tech/Sci/R&D Officer	20/04/2021
MERCK KGAA	Corporate Officer/Principal	01/01/2015
Merck Research Laboratories Massachusetts LLC Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products	Director/Board Member	01/07/2009
MERCK & CO., INC.	Corporate Officer/Principal	01/01/2009
Merck Sharp & Dohme Research Laboratories Neuroscience Researc	Corporate Officer/Principal	01/01/2005

See the detail of Mark Shearman's experience

Training of Mark Shearman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Shearman's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Merck & Co., Inc. Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines	Health Technology
Merck KGaA Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products	Health Technology
University of Bristol University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Beacon Therapeutics (USA), Inc. Beacon Therapeutics (USA), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development company that provides gene therapy development & clinical research services	Health Technology
The University of Nottingham The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
EMD Serono, Inc. EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines	Health Technology
Merck Research Laboratories Massachusetts LLC Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products	Health Technology
Editas Medicine, Inc. Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines	Health Technology
Merck Sharp & Dohme Research Laboratories Neuroscience Researc
Aprinoia Therapeutics, Inc. /US/ Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on neurodegenerative diseases	Health Technology